Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 20;2(2):100086.
doi: 10.1016/j.jacig.2023.100086. eCollection 2023 May.

A genome-wide association study for allergen component sensitizations identifies allergen component-specific and allergen protein group-specific associations

Affiliations

A genome-wide association study for allergen component sensitizations identifies allergen component-specific and allergen protein group-specific associations

Wataru Morii et al. J Allergy Clin Immunol Glob. .

Abstract

Background: Allergic diseases are some of the most common diseases worldwide. Genome-wide association studies (GWASs) have been conducted to elucidate the genetic factors of allergic diseases. However, no GWASs for allergen component sensitization have been performed.

Objective: We sought to detect genetic variants associated with differences in immune responsiveness against allergen components.

Methods: The participants of the present study were recruited from the Tokyo Children's Health, Illness, and Development study, and allergen component-specific IgE level at age 9 years was measured by means of allergen microarray immunoassays. We performed GWASs for allergen component sensitization against each allergen (single allergen component sensitization, number of allergen components analyzed, n = 31), as well as against allergen protein families (allergen protein group sensitization, number of protein groups analyzed, n = 16).

Results: We performed GWAS on 564 participants of the Tokyo Children's Health, Illness, and Development study and found associations between Amb a 1 sensitization and the immunoglobulin heavy-chain variable gene on chromosome 14 and between Phl p 1 sensitization and the HLA class II region on chromosome 6 (P < 5.0 × 10-8). A GWAS-significant association was also observed between the HLA class II region and profilin sensitization (P < 5.0 × 10-8).

Conclusions: Our data provide the first demonstration of genetic risk for allergen component sensitization and show that this genetic risk is related to immune response genes including immunoglobulin heavy-chain variable gene and HLA.

Keywords: Genome-wide association study; HLA; IGHV; allergen components; immunogenetics.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Flow chart of the present study.
Fig 2
Fig 2
3-Dimensional Manhattan plots of GWAS against allergen components and protein group sensitization. The x-axis (chromosome) represents the genomic locations; the y-axis, the phenotypes (ie, allergen component/allergen protein group sensitizations); and the z-axis (-log10(P)), the -log10 (P values).
Fig 3
Fig 3
GWAS for sensitization against Amb a 1. A, Manhattan plot for GWAS with sensitization against Amb a 1. The x-axis indicates chromosomal positions, and the y-axis, the −log10 (P values) calculated with SAIGE. The red line indicates the genome-wide significance level (P = 5.0 × 10−8), and the blue line, the genome-wide suggestive level (P = 1.0 × 10−5). B, Quantile-quantile (Q-Q) plot of GWAS with sensitization against Amb a 1. The Q-Q plot indicates the expected −log10 (P values) vs the observed −log10 (P values). C, Regional association plots of the GWAS-significant region on chromosome 14. Variants are colored according to their linkage disequilibrium (LD) based on the 1000 Genomes Project Phase 3’s EAS reference panel, and the top-associated SNP (rs35735004) is marked with a purple diamond. D, Regional association plots of the GWAS-significant region on chromosome 14 after conditioning on the top-associated SNP (rs35735004).
Fig 4
Fig 4
GWAS for sensitization against Phl p 1. A, Manhattan plot for GWAS with sensitization against Phl p 1. B, Association results of HLA class II alleles. The x-axis shows the HLA alleles, and the y-axis, the −log10 (P values). The red line indicates the genome-wide significance level (P = 5.0 × 10−8), and the blue line, the suggestive level (P = 1.0 × 10−5). C, Association results of 4-digit HLA class II alleles. Each circle point shows the −log10 (P values) for the 4-digit HLA class II alleles. The red line indicates the genome-wide significance level (P = 5.0 × 10−8), and the blue line, the genome-wide suggestive level (P = 1.0 × 10−5). D, Association results of HLA class II amino-acid polymorphisms. Each circle point shows the −log10 (P values) for each amino-acid polymorphism. The x-axis indicates the amino-acid positions. The red line indicates the genome-wide significance level (P = 5.0 × 10−8), and the blue line, the genome-wide suggestive level (P = 1.0 × 10−5).
Fig 5
Fig 5
GWAS for sensitization against profilin. A, Manhattan plot for GWAS with sensitization against profilin. B, Association results of HLA class II alleles. The x-axis shows the HLA alleles, and the y-axis, the −log10 (P values). The red line indicates the genome-wide significance level (P = 5.0 × 10−8), and the blue line, the genome-wide suggestive level (P = 1.0 × 10−5). C, Association results of 4-digit HLA class II alleles. Each circle point shows the −log10 (P values) for the 4-digit HLA class II alleles. The red line indicates the genome-wide significance level (5.0 × 10−8), and the blue line, the genome-wide suggestive level (1.0 × 10−5). D, Association results of HLA class II amino-acid polymorphisms. Each circle point shows the −log10 (P values) for each amino-acid polymorphism. The x-axis indicates the amino-acid positions. The red line indicates the genome-wide significance level (5.0 × 10−8), and the blue line, the genome-wide suggestive level (1.0 × 10−5).

Similar articles

References

    1. Dierick B.J.H., van der Molen T., Flokstra-de Blok B.M.J., Muraro A., Postma M.J., Kocks J.W.H., et al. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert Rev Pharmacoecon Outcomes Res. 2020;20:437–453. - PubMed
    1. Morikawa E., Sasaki M., Yoshida K., Adachi Y., Odajima H., Akasawa A. Nationwide survey of the prevalence of wheeze, rhino-conjunctivitis, and eczema among Japanese children in 2015. Allergol Int. 2020;69:98–103. - PubMed
    1. du Toit G., Tsakok T., Lack S., Lack G. Prevention of food allergy. J Allergy Clin Immunol. 2016;137:998–1010. - PubMed
    1. Resch Y., Michel S., Kabesch M., Lupinek C., Valenta R., Vrtala S. Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children. J Allergy Clin Immunol. 2015;136:1083–1091. - PMC - PubMed
    1. Curin M., Garib V., Valenta R. Single recombinant and purified major allergens and peptides: how they are made and how they change allergy diagnosis and treatment. Ann Allergy Asthma Immunol. 2017;119:201–209. - PMC - PubMed